FDA: Imaging, not aspirate tests, is the way to screen for breast cancer

12/19/2013 | Plain Dealer (Cleveland), The

Patients and clinicians should be aware that nipple aspirate tests do not deliver on common claims that suggest they are a good mammogram alternative, according to the FDA. "The key thing is that there really is only one exam whose value has been identified and supported by large, population-based clinical trials -- mammography," said Dr. Michael McNamara. "We use [ultrasound and biopsy] as an adjunct."

View Full Article in:

Plain Dealer (Cleveland), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA